Analyzing the BioLife Science Conference, we find a gathering of researchers and investors exploring life sciences advancements. While the event showcases a range of topics from antibodies to CNS therapies, New York-based Nionyx Bio's AAV capsid platform for gene therapies targeting kidney disease stands out as a notable achievement in the Startup Spotlight competition. Additionally, panelists discuss potential benefits of European biopharma sourcing funding locally, partly due to the recently l...